January 2016

FDA approves Integra matrix for DFUs

The US Food and Drug Administration on January 7 approved Plainsboro, NJ-based Integra’s Omnigraft Dermal Regeneration Matrix to treat diabetic foot ulcers (DFUs) that haven’t healed after six weeks and don’t involve exposure of the joint capsule, tendon, or bone.

The matrix device is used in conjunction with standard diabetic ulcer care and is made of silicone, cow collagen, and shark cartilage.

(Visited 6 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *

Spam Blocker * Time limit is exhausted. Please reload CAPTCHA.

This site uses Akismet to reduce spam. Learn how your comment data is processed.